Sclerotherapy for intramuscular vascular malformations: A single-center experience

Abstract

BackgroundVascular malformations isolated to skeletal muscles are rare and often debilitating due to pain and very challenging to treat. Multi-modal management options include compression garments, medical therapy, sclerotherapy, and surgical resection. MethodsA retrospective review of patients who underwent sclerotherapy for intramuscular venous malformations (IVM) between 2008 and 2016 was performed. Demographics, indications, and clinical follow-up were analyzed. ResultsTwenty patients underwent sclerotherapy for IVM. Six males and 14 females underwent 58 procedures. All patients presented with pain and were treated initially with compression garments. Median age at first treatment was 13years (+/− 5.06years). Initial protocol consisted of 2 sclerotherapy procedures with sodium tetradecyl sulfate (STS) within a 2–3month interval. Median volume of the lesion was 40cm3 (+/− 28.7), mostly located in the lower extremities (15/20). Median number of treatments was 2 (+/− 1.95). Treatment prior to puberty resulted in a median symptom-free time of 4years (+/− 2.18), while after puberty resulted in a symptom-free time of 2years (+/− 2.28). Two patients had an underlying coagulopathy and were admitted for observation and peri-procedural Lovenox. No procedure related complications were noted with a median follow-up of 4years (+/− 2.27). ConclusionIVMs are rare but can be incapacitating secondary to pain. Sclerotherapy is a useful minimally invasive procedure generally requiring at least two consecutive treatments. Treatment of patients prior to puberty appears to provide a more durable result, and surgical resection may be avoided. Type of studyretrospective. Level of evidenceIV